- Natriuretic Peptides (BNP And NT-ProBNP)
- Ischemia Modified Albumin
- Creatine Kinase
- Myoglobin
- Troponins (T,I)
- Others
The global cardiac biomarkers market size valued USD 13.08 billion in 2021 and expected to reach USD 25.08 billion by 2028, at a CAGR of 10.08% during the forecast period 2022-2028. Cardiac biomarkers are the substances that usually released into the blood when the heart is stressed or damaged. They are helpful in the diagnosis of an acute coronary syndrome (ACS) and cardiac ischemia, and other conditions associated with insufficient blood flow to the heart. The test for cardiac biomarkers is used to determine an individual’s risk of having the above conditions. A cardiac biomarker is a protein-based molecule that may be quantified for heart disease prognosis and diagnosis. When the heart is injured or stressed, such as from a lack of oxygen, cardiac biomarkers are released into the bloodstream. Cardiovascular biomarkers including cardiac troponin, creatinine kinase, myoglobin, and others are used to diagnose disorders like ACS and heart ischemia.
Cardiac Biomarkers Market Summary
Study Period
2023-29
Base Year
2022
CAGR
10%
Largest Market
North-America
Fastest Growing Market
Asia-Pacific
Cardiac Biomarkers Market Dynamics
Increase in the prevalence of cardiovascular diseases anticipated to drive the growth of the cardiac biomarkers market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) take the lives of 17.7 million people every year, 31% of all global deaths. Growing awareness among the people regarding the early diagnosis of the disease is expected to fuel the market. The factors such as highly accurate results and point of care testing are driving the growth of the market. However, the poor reimbursement policies are likely to hamper the growth of the market. The stringent government regulations for test approvals are hindering the growth of the cardiac biomarkers market.
North-America got significant share
Cardiac Biomarkers Market
Geographically, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America market is the dominant market when compared with that of other regional markets owing to its deep-rooted healthcare infrastructure. The adoption of the modern diagnosis and treatment methods for cardiac disease is adding fuel for the growth of the market. Europe cardiac biomarkers market falls next to that of North America region in the global cardiac biomarkers market. The Asia Pacific cardiac biomarkers market is expected to grow over the forecast period owing to increase in the prevalence of the cardiac diseases. The developing healthcare infrastructure is adding fuel for the growth of the cardiac biomarkers market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Cardiac Biomarkers Market Segmentation
Biomarker Type
Disease Type
- Acute Coronary Syndrome
- Congestive Heart Failure
- Atherosclerosis
- Myocardial Infarction
- Others
By End User
- Laboratory Testing
- Point of Care Testing
LOCATION
Geography
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Table of Content
- Executive Summary
- Global Cardiac Biomarkers Market Introduction
- Global Cardiac Biomarkers Market – Taxonomy
- Global Cardiac Biomarkers Market –Definitions
- Biomarker Type
- Disease Type
- Global Cardiac Biomarkers Market Dynamics
- Drivers
- Restraints
- Opportunities/Unmet Needs of the Market
- Trends
- Global Cardiac Biomarkers Market Dynamic Factors - Impact Analysis
- Global Cardiac Biomarkers Market – Competition Landscape
- Epidemiology
- Global Cardiac Biomarkers Market Analysis,2013 - 2017 and Forecast, 2018 – 2024
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%)
- Market OpportunityAnalysis
- Global Cardiac Biomarkers Market, By Biomarker Type, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Natriuretic Peptides (BNP And NT-ProBNP)
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Ischemia Modified Albumin
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Creatine Kinase
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Myoglobin
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Troponins (T,I)
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Others
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Natriuretic Peptides (BNP And NT-ProBNP)
- Global Cardiac Biomarkers Market Forecast, By Disease Type, 2013 - 2017 and Forecast, 2018 – 2024
- Acute Coronary Syndrome
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Congestive Heart Failure
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Atherosclerosis
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Myocardial Infarction
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Others
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Acute Coronary Syndrome
- Global Cardiac Biomarkers Market Forecast, By End User, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Laboratory Testing
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Point of Care Testing
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Laboratory Testing
- Global Cardiac Biomarkers Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- North America
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Europe
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Asia-Pacific
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Latin America
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Middle East and Africa
- Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Global Cardiac Biomarkers Market - Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User,and Region, 2018 – 2024
- North America
- North America Cardiac Biomarkers MarketAnalysis,2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Natriuretic Peptides (BNP And NT-ProBNP)
- Ischemia Modified Albumin
- Creatine Kinase
- Myoglobin
- Troponins (T,I)
- Others
- Disease Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Acute Coronary Syndrome
- Congestive Heart Failure
- Atherosclerosis
- Myocardial Infarction
- Others
- End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Laboratory Testing
- Point of Care Testing
- Country Analysis 2016 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- US
- Canada
- North America Cardiac Biomarkers Market - Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
- North America Cardiac Biomarkers Market Dynamics – Trends
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Europe Cardiac Biomarkers Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Natriuretic Peptides (BNP And NT-ProBNP)
- Ischemia Modified Albumin
- Creatine Kinase
- Myoglobin
- Troponins (T,I)
- Others
- Disease Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Acute Coronary Syndrome
- Congestive Heart Failure
- Atherosclerosis
- Myocardial Infarction
- Others
- End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Laboratory Testing
- Point of Care Testing
- Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Poland
- Rest of Europe
- Europe Cardiac Biomarkers Market - Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
- Europe Cardiac Biomarkers Market Dynamics – Trends
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Asia-Pacific Cardiac Biomarkers Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Natriuretic Peptides (BNP And NT-ProBNP)
- Ischemia Modified Albumin
- Creatine Kinase
- Myoglobin
- Troponins (T,I)
- Others
- Disease Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Acute Coronary Syndrome
- Congestive Heart Failure
- Atherosclerosis
- Myocardial Infarction
- Others
- End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Laboratory Testing
- Point of Care Testing
- Country Analysis2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- Japan
- China
- India
- ASEAN
- Australia & New Zealand
- Rest of Asia-Pacific
- Asia-Pacific Cardiac Biomarkers Market - Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
- Asia-Pacific Cardiac Biomarkers Market Dynamics – Trends
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Latin America Cardiac Biomarkers Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Natriuretic Peptides (BNP And NT-ProBNP)
- Ischemia Modified Albumin
- Creatine Kinase
- Myoglobin
- Troponins (T,I)
- Others
- Disease Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Acute Coronary Syndrome
- Congestive Heart Failure
- Atherosclerosis
- Myocardial Infarction
- Others
- End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Laboratory Testing
- Point of Care Testing
- Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Latin America Cardiac Biomarkers Market - Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
- Latin America Cardiac Biomarkers Market Dynamics – Trends
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Middle East and Africa Cardiac Biomarkers Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Natriuretic Peptides (BNP And NT-ProBNP)
- Ischemia Modified Albumin
- Creatine Kinase
- Myoglobin
- Troponins (T,I)
- Others
- Disease Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Acute Coronary Syndrome
- Congestive Heart Failure
- Atherosclerosis
- Myocardial Infarction
- Others
- End User Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Laboratory Testing
- Point of Care Testing
- Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
- MEA Cardiac Biomarkers Market - Opportunity Analysis Index, By Biomarker Type, By Disease Type, By End User, and Country, 2018 – 2024
- MEA Cardiac Biomarkers Market Dynamics – Trends
- Biomarker Type Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Competition Landscape
- Strategic Dashboard of Top Market Players
- Company Profiles (Introduction, Financial Analysis, Biomaker Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
- Randox laboratories (UK)
- Thermo Fisher Scientific (U.S)
- Roche Diagnostics (Switzerland)
- Abbott Laboratories (U.S)
- Siemens Healthcare (Germany)
- Alere Inc. (U.S)
- Becton, Dickinson and Company (U.S)
- Bio-Rad Laboratories (U.S)
- BioMerieux (France)
- Beckman Coulter (U.S)
- Research Methodology
- Key Assumptions and Acronyms
- Disclaimer
- The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.
- Randox laboratories (UK)
- Thermo Fisher Scientific (U.S)
- Roche Diagnostics (Switzerland)
- Abbott Laboratories (U.S)
- Siemens Healthcare (Germany)
- Alere Inc. (U.S)
- Becton, Dickinson and Company (U.S)
- Bio-Rad Laboratories (U.S)
- BioMerieux (France)
- Beckman Coulter (U.S)